Athira Pharma is Conducting Clinical Trials of ATH-1017

“ATH-1017 is a fact acting, novel approach that may have long lasting results”.

Example Mechanism of Action (MOA) video for Alzheimer’s disease. Same MOA and therapeutic potential may apply for Parkinson’s Disease Dementia.